Athena Diagnostics, Inc.

Athena Diagnostics is a clinical diagnostics service testing laboratory that focuses on neurology, endocrinology, and nephrology. The company has established itself as a leader in genetic testing and personalized medicine with a mission to enhance the lives of patients through top-notch diagnostic services. Originally founded as Genica Pharmaceuticals in 1988, Athena Diagnostics has experienced several changes in ownership over the years, being acquired by Athena Neuroscience in 1995, Elan Pharmaceuticals in 1996, Behrman Capital in 2002, Fisher Scientific in 2006 (which later became Thermo Fisher), and ultimately Quest Diagnostics in 2011. With over 300 diagnostic tests and a workforce of 300 employees, the company generated $110 million in revenues in 2010.

Athena Diagnostics operates in the biotechnology and healthcare sectors, with its headquarters located in the United States. Despite the absence of recent investment details, the company's rich history, diversified portfolio of diagnostic tests, and substantial revenue figures make it an intriguing prospect for potential investors or venture capitalists looking to enter the clinical diagnostics space.